These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 17203867)

  • 21. Local Ugandan Production of Stable 0.2% Chlorhexidine Eye Drops.
    Picken CAR; Brocchini S; Burton MJ; Blundell-Hunter G; Kuguminkiriza D; Kaur H; Hoffman JJ; Arunga S; Mohamed-Ahmed AHA
    Transl Vis Sci Technol; 2023 Jan; 12(1):27. PubMed ID: 36705928
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antimicrobial activity of a new preservative for multiuse ophthalmic solutions.
    Ghelardi E; Celandroni F; Gueye SA; Salvetti S; Campa M; Senesi S
    J Ocul Pharmacol Ther; 2013; 29(6):586-90. PubMed ID: 23428175
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ofloxacin monotherapy for the primary treatment of microbial keratitis: a double-masked, randomized, controlled trial with conventional dual therapy. The Ofloxacin Study Group.
    Ophthalmology; 1997 Nov; 104(11):1902-9. PubMed ID: 9373124
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of the force effect of aqueous and oily eye drops.
    Müller F; Wagner M; Neubert RH
    Pharmazie; 2005 Apr; 60(4):283-7. PubMed ID: 15881609
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Synthesis, physico-chemical and antimicrobial activities of 1-alkyl-2-(pyridyl)pyridinium bromides].
    Zámocká J; Lacko I; Devínsky F
    Pharmazie; 1994 Jan; 49(1):66-7. PubMed ID: 8140134
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparison of the antimicrobial activity of cefuroxime with other oral antibiotics.
    Wiedemann B; Heisig P
    J Chemother; 1989 Jul; 1(4 Suppl):93-6. PubMed ID: 16312320
    [No Abstract]   [Full Text] [Related]  

  • 27. Stability of ceftazidime (with arginine) and of cefuroxime sodium in infusion-pump reservoirs.
    Stiles ML; Allen LV; Fox JL
    Am J Hosp Pharm; 1992 Nov; 49(11):2761-4. PubMed ID: 1471642
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preservation of Biological Activity of Plasma and Platelet-Derived Eye Drops After Their Different Time and Temperature Conditions of Storage.
    Anitua E; de la Fuente M; Riestra A; Merayo-Lloves J; Muruzábal F; Orive G
    Cornea; 2015 Sep; 34(9):1144-8. PubMed ID: 26165790
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Antibiotic stability in magistral collyria].
    Tihărău A; Voiculescu E; Vancea S; Teodorescu A; Cherecheş S
    Oftalmologia; 1990; 34(2):97-104. PubMed ID: 2101048
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of the freezing conditions and microwave thawing power on the stability of cefuroxime in dextrose 5% infusion polyolefin bags at 4 degrees C.
    Hecq JD; Boitquin LP; Vanbeckbergen DF; Jamart J; Galanti LM
    Ann Pharmacother; 2005; 39(7-8):1244-8. PubMed ID: 15956230
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Formulation of Carbopol 940 ophthalmic vehicles, and in vitro evaluation of the influence of simulated lacrimal fluid on their physico-chemical properties.
    Unlü N; Ludwig A; van Ooteghem M; Hincal AA
    Pharmazie; 1991 Nov; 46(11):784-8. PubMed ID: 1811229
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Development of technology of sodium cromoglycate eye drops].
    Inkeniene AM; Klimas R; Ramanauskiene K
    Medicina (Kaunas); 2005; 41(7):584-91. PubMed ID: 16062026
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro compatibility study of cephalosporin with intraocular irrigating solutions and intracameral medications.
    Hui M; Lam PT; Cheung SW; Pang CP; Chan CY; Lam DS
    Clin Exp Ophthalmol; 2011 Mar; 39(2):164-70. PubMed ID: 20796261
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potency and Sterility of Fortified Tobramycin, Fortified Vancomycin, and Moxifloxacin at 4, 24, and 35°C for 14 Days.
    Montes JA; Johnson D; Jorgensen J; McElmeel ML; Fulcher LC; Kiel JW
    Cornea; 2016 Jan; 35(1):122-6. PubMed ID: 26555587
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Galenic validation of plasma rich in growth factors eye drops.
    Anitua E; Muruzábal F; Riestra A; De la Fuente M; Merayo-Lloves J
    Farm Hosp; 2019 Mar; 43(2):45-49. PubMed ID: 30848175
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biological Stability of Plasma Rich in Growth Factors Eye Drops After Storage of 3 Months.
    Anitua E; Muruzabal F; Pino A; Merayo-Lloves J; Orive G
    Cornea; 2013 Oct; 32(10):1380-6. PubMed ID: 23974892
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Sodium sulfapyridazine in new delayed-action bases for the treatment of bacterial conjunctivitis].
    Maĭchuk IuF; Pozdniakov VI; Kur'iazov IK; Moldaver BL; Rusak AV
    Antibiot Khimioter; 1991 Apr; 36(4):26-8. PubMed ID: 1892429
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Short- and Long-Term Stability of Plasma Rich in Growth Factors Eye Drops.
    Anitua E; de la Fuente M; Muruzábal F; Merayo-Lloves J
    Cornea; 2021 Jan; 40(1):107-112. PubMed ID: 32947409
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Comparative study of the antimicrobial activity of natural and synthesized phenylheptatriyne and its derivatives].
    Bondarenko AS; Kuznetsov NV; Krasavtsev II; Mishenkova EL; Petrenko GT
    Mikrobiol Zh (1978); 1985; 47(3):101-4. PubMed ID: 3916959
    [No Abstract]   [Full Text] [Related]  

  • 40. Design and evaluation of pharmaceutical availability, stability and quality of modified viscosity eye drops with choline salicylate.
    Wróblewska KB; Plewa S; Długaszewska J; Froelich A; Muszalska-Kolos I
    Eur J Pharm Sci; 2021 Apr; 159():105725. PubMed ID: 33482319
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.